Treatment patterns, outcomes and testing in EGFRm NSCLC patients with EGFR TKI 1L across Europe (REFLECT)

Trial Identifier:	D5162R00009
Sponsor:	AstraZeneca
NCTID::	NCT04031898
Start Date:	May 2019
Primary Completion Date:	December 2019
Study Completion Date:	December 2019
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Bulgaria	Wien, Bulgaria, 1140

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.